Literature DB >> 1111453

Efficacy of intravenous clindamycin and methicillin in gram-positive soft tissue infections.

K C Chessick, L A Begley, L E Curtis, E F Hirsch, C W Kaiser, C A Burek, H S Soroff.   

Abstract

In a comparative study on a general surgical service, intravenous clindamycin phosphate or methicillin was used to treat a variety of soft tissue infections due to gram-positive organisms, chiefly staphylococci. The infections were rated according to severity, responsible organisms, and site of the infection. Excellent or good clinical and bacteriologic responses were obtained with both clindamycin and methicillin as adjuncts to basic surgical therapy in these soft tissue infections. The adverse effects of each drug were detailed, and were comparable. Clindamycin phosphate is a satisfactory substitute for methicillin in soft tissue infections secondary to gram-positive organisms.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1111453      PMCID: PMC1343754          DOI: 10.1097/00000658-197502000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  20 in total

1.  Treatment of anaerobic infections with lincomycin and clindamycin.

Authors:  J G Bartlett; V L Sutter; S M Finegold
Journal:  N Engl J Med       Date:  1972-11-16       Impact factor: 91.245

2.  Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin.

Authors:  R F McGehee; C B Smith; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1968-11       Impact factor: 2.378

3.  Clinical and bacteriological studies with clindamycin.

Authors:  A M Geddes; F A Bridgwater; D N Williams; J Oon; G J Grimshaw
Journal:  Br Med J       Date:  1970-06-20

Review 4.  Methicillin: critical appraisal after a decade of experience.

Authors:  D N Gilbert; J P Sanford
Journal:  Med Clin North Am       Date:  1970-09       Impact factor: 5.456

5.  Unusual resistance of Staphylococcus aureus to lincomycin and 7-chlorolincomycin.

Authors:  E J Benner; A P Adams
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

6.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

7.  Clinical and laboratory experience with clindamycin.

Authors:  H G Stiver; A R Ronald
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

8.  Comparison of in vitro antibacterial activities of 7-chloro-7-deoxylincomycin, lincomycin, and erythromycin.

Authors:  D W Garrison; R M DeHaan; J B Lawson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

9.  Clindamycin palmitate in healthy men: general tolerance and effect on stools.

Authors:  R M De Haan; D Schellenberg; W D Vanden Bosch; M H Maile
Journal:  Curr Ther Res Clin Exp       Date:  1972-02

10.  Therapy of staphylococcal infections in monkeys. VI. Comparison of clindamycin, erythromycin, and methicillin.

Authors:  H N Carlisle; S Saslaw
Journal:  Appl Microbiol       Date:  1971-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.